Share

March 19, 2013; 80 (12) Article

Vestibular compensation in acute unilateral medullary infarction

FDG-PET study

Sandra Becker-Bense, Hans-Georg Buchholz, Christoph Best, Mathias Schreckenberger, Peter Bartenstein, Marianne Dieterich
First published February 20, 2013, DOI: https://doi.org/10.1212/WNL.0b013e31828868a6
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
190

Share

Article Information

vol. 80 no. 12 1103-1109
DOI: 
https://doi.org/10.1212/WNL.0b013e31828868a6
PubMed: 
23427323
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received May 7, 2012
  • Accepted December 5, 2012
  • First Published February 20, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Sandra Becker-Bense, MD,
    2. Hans-Georg Buchholz, PhD,
    3. Christoph Best, MD,
    4. Mathias Schreckenberger, MD,
    5. Peter Bartenstein, MD and
    6. Marianne Dieterich, MD
  1. Sandra Becker-Bense, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Hans-Georg Buchholz, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Christoph Best, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. Research Grant by the Johannes Gutenberg-University, Mainz, Germany: Mainzer Research Support, MAIFOR.

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Mathias Schreckenberger, MD,
    5. Scientific Advisory Boards:

    1. Scientific Advisory Board “Neuroendocrine Tumors” (Novartis Pharma)

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Speaker Honoraria (Ipsen Pharma)

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. - German Research Foundation(DFG), - Rhineland-Palatinate Foundation for Innovation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Peter Bartenstein, MD and
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Siemens, General Electric, Bayer Schering

    Research Support, Government Entities:

    1. Deutsche Forschungsgemeinschaft (SFB 824) Bundesministerium für Bildung und Forschung (Spitzencluster m4) European Union 7th framework Program (EURIPIDES)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Marianne Dieterich, MD
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Annals of Neurology Editorial Board

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. BMBF ministry for research

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Neurology (S.B.-B., M.D.) and Nuclear Medicine (P.B.), University of Munich; Departments of Nuclear Medicine (H.-G.B., M.S.) and Neurology (C.B.), Johannes Gutenberg-University Mainz; German Center for Vertigo and Balance Disorders (IFBLMU) (S.B.-B., P.B., M.D.), University of Munich; and Munich Cluster for Systems Neurology (SyNergy) (M.D.), Munich, Germany.
  1. Correspondence to Dr. Becker-Bense: sandra.bense{at}med.uni-muenchen.de
View Full Text

Article usage

Article usage: February 2013 to February 2023

AbstractFullPdfSource
Feb 2013147010Highwire
Mar 201311771628Highwire
Apr 20132891516Highwire
May 201315988Highwire
Jun 20135355Highwire
Jul 20134714Highwire
Aug 20135535Highwire
Sep 20135613Highwire
Oct 20134852Highwire
Nov 20135202Highwire
Dec 20134400Highwire
Jan 20143754Highwire
Feb 20143431Highwire
Mar 20145122Highwire
Apr 20144912Highwire
May 20142410Highwire
Jun 20142123Highwire
Jul 20143600Highwire
Aug 2014943Highwire
Sep 20141422Highwire
Oct 20142312Highwire
Nov 2014833Highwire
Dec 20141522Highwire
Jan 20151511Highwire
Feb 20151303Highwire
Mar 20153513Highwire
Apr 20151010Highwire
May 20151550Highwire
Jun 20151632Highwire
Jul 20152232Highwire
Aug 20152600Highwire
Sep 20151800Highwire
Oct 20151510Highwire
Nov 20153612Highwire
Dec 20152102Highwire
Jan 20162210Highwire
Feb 20162511Highwire
Mar 20161500Highwire
Apr 20161300Highwire
May 2016900Highwire
Jun 20162211Highwire
Jul 20161812Highwire
Aug 20161200Highwire
Sep 20161411Highwire
Oct 20161401Highwire
Nov 20161621Highwire
Dec 20162012Highwire
Jan 20171100Highwire
Feb 20171400Highwire
Mar 20171000Highwire
Apr 20171611Highwire
May 20171600Highwire
Jun 2017200Highwire
Jul 2017701Highwire
Aug 2017700Highwire
Sep 20171200Highwire
Oct 20171500Highwire
Nov 20171000Highwire
Dec 20171300Highwire
Jan 20182501Highwire
Feb 20181904Highwire
Mar 20182301Highwire
Apr 20183501Highwire
May 20187600Highwire
Jun 20183900Highwire
Jul 20183300Highwire
Aug 2018800Highwire
Sep 2018902Highwire
Oct 20182111Highwire
Nov 20182512Highwire
Dec 20183402Highwire
Jan 20192812Highwire
Feb 20191800Highwire
Mar 20191811Highwire
Apr 20191100Highwire
May 20191600Highwire
Jun 20191300Highwire
Jul 20191511Highwire
Aug 20192101Highwire
Sep 20191701Highwire
Oct 20191801Highwire
Nov 20192400Highwire
Dec 20192001Highwire
Jan 20203503Highwire
Feb 20202001Highwire
Mar 20202912Highwire
Apr 2020401Highwire
May 2020801Highwire
Jun 20201300Highwire
Jul 2020900Highwire
Aug 2020700Highwire
Sep 20201302Highwire
Oct 20201110Highwire
Nov 20201110Highwire
Dec 20201421Highwire
Jan 2021921Highwire
Feb 202110900Highwire
Mar 20214901Highwire
Apr 20213033Highwire
May 20212100Highwire
Jun 2021901Highwire
Jul 20213202Highwire
Aug 20212200Highwire
Sep 20211100Highwire
Oct 20211500Highwire
Nov 20211700Highwire
Dec 20211103Highwire
Jan 20223211Highwire
Feb 20221711Highwire
Mar 20221620Highwire
Apr 20222200Highwire
May 20222600Highwire
Jun 20221201Highwire
Jul 2022511Highwire
Aug 20221210Highwire
Sep 2022800Highwire
Oct 20221706Highwire
Nov 20221700Highwire
Dec 20221001Highwire
Jan 20231601Highwire
Feb 2023611Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me

Recommended articles